Granata Bio Corporation ("Granata Bio"), a biopharma company focused on invigorating the $3.6B global infertility medication market, today announced its $15M Series A+ funding round. The round was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback